BioCentury | Mar 28, 2021
Finance
Launched by Pharmacyclics vets, preclinical cancer start-up Biomea Fusion seeks short path to IPO
...Technology and Quality Officer Heow Tan, who held the same position at Pharmacyclics.Pharmacyclics developed Imbruvica ibrutinib...